MedPath

Management of Pre-Menstrual Symptoms with the help of Brahmi churna and Jatamansi churna capsule

Phase 2
Conditions
Health Condition 1: E35- Disorders of endocrine glands in diseases classified elsewhere
Registration Number
CTRI/2023/07/055516
Lead Sponsor
Parul Institute Of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Age between 18 yrs to 40 yrs of age irrespective of socio economic status and in good medical health

2. Female subjects having regular menstrual cycle with cycle length of 21-35 days.

3. Having a minimum PMTS score >10 and VAS score >1

4. Symptoms should appear at definite time in luteal phase of the cycle.

5. The subject should be symptomatic for a period of last 3 or more than 3 months.

6. Symptoms should not persist beyond the 5th day of menstrual cycle.

7. The subjects who are ready to follow the treatment protocol and sign the informed consent.

Exclusion Criteria

1. Women aged below 18 and above 40 years

2. Subject suffering from other acute or chronic psychiatric illness.

3. Those with symptoms existing less than 3 menstrual cycles.

4. Subjects having diabetes mellitus, hypertension, thyroid, PCOS, DUB

5. Subjects suffering from organic brain diseases.

6. Subjects under hormonal and psychiatric treatment.

7. Subjects taking oral contraceptive pills.

8. Subjects with premenstrual dysphoric disorder

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To subside Pre-Menstrual SymptomsTimepoint: 30 days
Secondary Outcome Measures
NameTimeMethod
Improvement in quality of life.Timepoint: The outcomes will be measured after screening at Base Line BT after 1 month & at the end of 2 months AT Assessment of clinical parameters will also be done at the end of the 3rd month after 1 month of medicine free period
© Copyright 2025. All Rights Reserved by MedPath